Framework agreement for acoramidis 356 mg tablets

Summary

Amgros I/S is procuring a framework agreement for acoramidis 356 mg tablets for the hospital pharmacies of Denmark’s regions, with possible resale to the Faroe Islands and Greenland. The procurement comprises one separately awarded lot, with an estimated quantity of 76,380 units; actual consumption may differ and the agreement does not require purchases.